Literature DB >> 31814890

LncRNA HOXA11-AS accumulation-induced microRNA-761 downregulation regulates cell growth by targeting TRIM29 in papillary thyroid cancer.

Xiangdang Yin1, Jian Zhang2, Chaojun Li1, Zhe Zhang1, Tong Jin1, Liyou Song1, Rui Zhang1, Wei Wang1, Youmao Tao3, Xiaochun Wang1.   

Abstract

Increasing evidence demonstrate that dysregulated microRNAs (miRNAs) are involved in carcinogenesis and tumor progression in papillary thyroid cancer (PTC). However, the specific miR-761 in cancer remains largely unknown. In this study, we reported for the first that miR-761 expression was down-regulated in PTC tissues and cell lines, and its decrease was associated with tumor size and TNM stage. Gain- and loss-of function experiments revealed that miR-761 inhibited cell proliferation, colony formation and cell cycle progression in vitro and in vivo. Moreover, TRIM29 was identified as a direct downstream target of miR-761 in PTC cells and mediated the functional effects of miR-761 in PTC. Restoration of TRIM29 expression at least partially abolished the biological effects of miR-761 on PTC cells. Furthermore, overexpression of lncRNA HOXA11-AS was inversely correlated with miR-761 expression in PTC tissues. LncRNA HOXA11-AS could modulate the miR-761 expression and regulate cellular behaviors. Taken together, this research supports the first evidence that lncRNA HOXA11-AS-reguated miR-761 plays a functional role in inhibiting PTC progression by targeting TRIM29 and represent a promising therapeutic strategy for patients with PTC. AJTR
Copyright © 2019.

Entities:  

Keywords:  HOXA11-AS; TRIM29; miR-761; proliferation; thyroid cancer

Year:  2019        PMID: 31814890      PMCID: PMC6895523     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  31 in total

1.  RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.

Authors:  Weihong Xu; Bin Xu; Yiting Yao; Xiaoling Yu; Hua Cao; Jun Zhang; Jie Liu; Huiming Sheng
Journal:  Oncol Rep       Date:  2016-07-15       Impact factor: 3.906

2.  High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.

Authors:  Si-Xiang Zeng; Qing-Chun Cai; Chi-Hua Guo; Li-Qiang Zhi; Xing Dai; Dang-Feng Zhang; Wei Ma
Journal:  Oncol Rep       Date:  2017-07-21       Impact factor: 3.906

Review 3.  Molecular analysis of thyroid tumors.

Authors:  Feriyl Bhaijee; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

4.  Hsa_circ_0007534/miR-761/ZIC5 regulatory loop modulates the proliferation and migration of glioma cells.

Authors:  Guang-Feng Li; Li Li; Zong-Qin Yao; Su-Jing Zhuang
Journal:  Biochem Biophys Res Commun       Date:  2018-04-10       Impact factor: 3.575

5.  Long Noncoding RNA HOXA11-AS Functions as miRNA Sponge to Promote the Glioma Tumorigenesis Through Targeting miR-140-5p.

Authors:  Yan Cui; Lei Yi; Ji-Zong Zhao; Yu-Gang Jiang
Journal:  DNA Cell Biol       Date:  2017-08-23       Impact factor: 3.311

6.  The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia.

Authors:  Muzaffer Dükel; W Scott Streitfeld; Tsz Ching Chloe Tang; Lindsey R F Backman; Lingbao Ai; W Stratford May; Kevin D Brown
Journal:  J Biol Chem       Date:  2016-08-17       Impact factor: 5.157

7.  Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.

Authors:  F Liu; J-H Yuan; J-F Huang; F Yang; T-T Wang; J-Z Ma; L Zhang; C-C Zhou; F Wang; J Yu; W-P Zhou; S-H Sun
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

8.  Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.

Authors:  Wenlei Li; Guotao Jia; Yanwen Qu; Qian Du; Baoguo Liu; Bin Liu
Journal:  Med Sci Monit       Date:  2017-07-13

9.  Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.

Authors:  Zhili Liu; Zhenyao Chen; Ruihua Fan; Bin Jiang; Xin Chen; Qinnan Chen; Fengqi Nie; Kaihua Lu; Ming Sun
Journal:  Mol Cancer       Date:  2017-04-26       Impact factor: 27.401

10.  Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.

Authors:  Gabriella Pellegriti; Francesco Frasca; Concetto Regalbuto; Sebastiano Squatrito; Riccardo Vigneri
Journal:  J Cancer Epidemiol       Date:  2013-05-07
View more
  13 in total

1.  Ursolic acid ameliorates Nthy-ori 3-1 cells injury induced by IL-1β through limiting MALAT1/miR-206/PTGS1 ceRNA network and NF-κB signaling pathway.

Authors:  Lunpan Mou; Liyan Liao; Yaping Zhang; Desong Ming; Jianjia Jiang
Journal:  Psychopharmacology (Berl)       Date:  2021-01-16       Impact factor: 4.530

2.  The abnormal expression of circ-ARAP2 promotes ESCC progression through regulating miR-761/FOXM1 axis-mediated stemness and the endothelial-mesenchymal transition.

Authors:  Pei Xu; Lei Wang; Qingtao Liu; Pengkai Gao; Fengqing Hu; Xiao Xie; Lianyong Jiang; Rui Bi; Fangbao Ding; Qi Yang; Haibo Xiao
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440

3.  Long non‑coding RNA HOXA11‑AS accelerates cell proliferation and epithelial‑mesenchymal transition in hepatocellular carcinoma by modulating the miR‑506‑3p/Slug axis.

Authors:  Yinghui Liu; Wenzhao Yan; Dongfang Zhou; Guohua Jin; Xin Cheng
Journal:  Int J Mol Med       Date:  2020-08-28       Impact factor: 4.101

4.  Radiation-induced acute injury of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a prospective cohort study.

Authors:  Zexin Yao; Bing Zhang; Jialin Huang; Lei Shi; Biao Cheng
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

5.  Imbalance of Molecular Module of TINCR-miR-761 Promotes the Metastatic Potential of Early Triple Negative Breast Cancer and Partially Offsets the Anti-Tumor Activity of Luteolin.

Authors:  Man-Li Zhang; Wei-Wei Liu; Wei-Dong Li
Journal:  Cancer Manag Res       Date:  2021-02-23       Impact factor: 3.989

6.  microRNA-181a promotes the oncogene S100A2 and enhances papillary thyroid carcinoma growth by mediating the expression of histone demethylase KDM5C.

Authors:  Y Wang; H Ye; Y Yang; J Li; A Cen; L Zhao
Journal:  J Endocrinol Invest       Date:  2021-06-18       Impact factor: 4.256

7.  Combined Impacts of Genetic Variants of Long Non-Coding RNA MALAT1 and the Environmental Carcinogen on the Susceptibility to and Progression of Oral Squamous Cell Carcinoma.

Authors:  Yi-Fang Ding; Yu-Ching Wen; Chun-Yi Chuang; Chiao-Wen Lin; Yi-Chieh Yang; Yu-Fan Liu; Wei-Min Chang; Lun-Ching Chang; Shun-Fa Yang; Ming-Hsien Chien
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

8.  Long non-coding RNA DLEUI promotes papillary thyroid carcinoma progression by sponging miR-421 and increasing ROCK1 expression.

Authors:  Rui Li; Taihu Wan; Jie Qu; Yang Yu; Ruipeng Zheng
Journal:  Aging (Albany NY)       Date:  2020-09-10       Impact factor: 5.682

9.  TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells.

Authors:  Tong Wu; Da-Lin Zhang; Jia-Mei Wang; Jing-Yi Jiang; Xin Du; Xiao-Yan Zeng; Zhen-Xian Du
Journal:  Cell Death Dis       Date:  2020-09-29       Impact factor: 8.469

10.  ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer.

Authors:  Youkun Jie; Lu Ye; He Chen; Xiaohong Yu; Li Cai; Wenfeng He; Yonghui Fu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.